Find a Commonwealth Resource
Belimumab
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Benlysta (belimumab) is a prescription medication from GlaxoSmithKline LLC, administered as a subcutaneous injection to inhibit B lymphocyte activation, helping manage autoimmune conditions like lupus. It comes in 200 mg/mL strength in prefilled syringes. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Belimumab
Access the FDA dataset for Belimumab — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025